Immunization with a plasmid expressing pneumococcal surface protein A (PspA) can elicit protection against fatal infection with Streptococcus pneumoniae

被引:0
作者
LS McDaniel
F Loechel
C Benedict
T Greenway
DE Briles
RM Conry
DT Curiel
机构
[1] Bacterial Pathogenesis Laboratory,Department of Microbiology
[2] The Comprehensive Cancer Center,Department of Surgery
[3] University of Mississippi Medical Center,The Division of Developmental and Clinical Immunology
[4] Gene Therapy Program,undefined
[5] Pulmonary and Critical Care Medicine,undefined
[6] The Comprehensive Cancer Center,undefined
[7] University of Alabama at Birmingham,undefined
[8] University of Alabama at Birmingham,undefined
来源
Gene Therapy | 1997年 / 4卷
关键词
PspA; pneumococcus; pneumococcal vaccine;
D O I
暂无
中图分类号
学科分类号
摘要
Pneumococcal surface protein A (PspA) is a protection-eliciting protein of Streptococcus pneumoniae. We observed that immunization of BALB/c mice with a plasmid expressing PspA significantly protected the mice from lethal challenge with S. pneumoniae when compared to control mice that received injections of the plasmid vector alone. The plasmid construct expressing PspA has been designated pKSD2601. Mice immunized intramuscularly with pKSD2601 had a mean log of colony-forming units of 2.97 ± 0.25 pneumococci circulating in their blood at 24 h after challenge as compared with control mice that had a mean log of colony-forming units of 4.95 ± 0.59. Those mice with lower numbers of pneumococci subsequently survived the challenge. Given the quantitative nature and ultimate end point (ie live versus dead) our mouse model should be useful in working out optimum expression of bacterial genes for DNA immunization.
引用
收藏
页码:375 / 377
页数:2
相关论文
empty
未找到相关数据